Literature DB >> 24316317

The influence of fatty acids on determination of human serum albumin thiol group.

Vesna B Jovanović1, Ivan D Pavićević1, Marija M Takić2, Ana Z Penezić-Romanjuk1, Jelena M Aćimović1, Ljuba M Mandić3.   

Abstract

During investigation of the changes of the Cys34 thiol group of human serum albumin (HSA) (isolated by affinity chromatography with Cibacron Blue (CB)) in diabetes, we found that the HSA-SH content was higher (11-33%) than the total serum thiol content. The influence of fatty acids (FA) binding to HSA on this discrepancy was investigated in vitro (using fluorescence and CD spectroscopy and GC) and with HSA samples from diabetic (n=20) and control groups (n=17). HSA-bound FA determine the selection of HSA molecules by CB and enhance reactivity and/or accessibility of the SH group. A high content of polyunsaturated FA (35.6%) leads to weaker binding of HSA molecules to CB. Rate constants of DTNB reaction with the SH group of HSA applied to a CB column, bound-HSA and unbound-HSA fractions, were 4.8×10(-3), 21.6×10(-3), and 11.2×10(-3) s(-1), respectively. The HSA-SH group of diabetics is more reactive compared with control individuals (rate constants 20.9×10(-3)±4.4×10(-3) vs 12.9×10(-3)±2.6×10(-3) s(-1), P<0.05). Recovery values of the SH group obtained after chromatography of HSA with bound stearic acid ranged from 110 to 140%, while those for defatted HSA were from 98.5 to 101.7%. Thus, HSA-bound FA leads to an increase of HSA-SH content and a contribution to total serum thiols, which make the determination of the thiol group unreliable.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Affinity chromatography; Albumin isolation; Diabetes; Fatty acid; HSA-thiol group determination

Mesh:

Substances:

Year:  2013        PMID: 24316317     DOI: 10.1016/j.ab.2013.11.030

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  4 in total

1.  Simultaneous optical detection of human serum albumin and transferrin in body fluids.

Authors:  Zolaikha Rasouli; Raouf Ghavami
Journal:  Mikrochim Acta       Date:  2020-03-09       Impact factor: 5.833

Review 2.  Unraveling the Interaction between FcRn and Albumin: Opportunities for Design of Albumin-Based Therapeutics.

Authors:  Kine Marita Knudsen Sand; Malin Bern; Jeannette Nilsen; Hanna Theodora Noordzij; Inger Sandlie; Jan Terje Andersen
Journal:  Front Immunol       Date:  2015-01-26       Impact factor: 7.561

3.  A Novel Detection Method of Human Serum Albumin Based on the Poly(Thymine)-Templated Copper Nanoparticles.

Authors:  Mingjian Chen; Xinying Xiang; Kefeng Wu; Hailun He; Hanchun Chen; Changbei Ma
Journal:  Sensors (Basel)       Date:  2017-11-21       Impact factor: 3.576

4.  Expression, purification and initial characterization of human serum albumin domain I and its cysteine 34.

Authors:  Martina Steglich; Rodrigo Lombide; Ignacio López; Madelón Portela; Martín Fló; Mónica Marín; Beatriz Alvarez; Lucía Turell
Journal:  PLoS One       Date:  2020-10-12       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.